{"id":6662,"date":"2019-01-11T15:43:19","date_gmt":"2019-01-11T20:43:19","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=6662"},"modified":"2019-01-11T15:43:19","modified_gmt":"2019-01-11T20:43:19","slug":"new-filings-updated-terms-12-21-18-1-11-19","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-12-21-18-1-11-19\/","title":{"rendered":"New Filings & Updated Terms (12.21.18-1.11.19)"},"content":{"rendered":"

NEW FILINGS<\/strong><\/span><\/p>\n

Company: Alector, Inc.
\nSymbol: ALEC
\nDescription: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays
\nFiled: 1-7-19
\nListed Cash Raise: $100m<\/p>\n

Company: Anchiano Therapeutics Ltd.
\nSymbol: ANCN
\nDescription: They are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer. Their ordinary shares are listed on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “ANCN”.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Oppenheimer & Co.
\nCo-Manager(s): Ladenburg Thalmann
\nFiled: 1-7-19
\nListed Cash Raise: $35m<\/p>\n

Company: Exeter Finance Corporation
\nSymbol: XTF
\nDescription: They are an industry leading, full-service, technology and data-driven specialty finance company, operating in the U.S. automobile finance market since April 2006.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Wells Fargo
\nFiled: 1-8-19
\nListed Cash Raise: $100m<\/p>\n

Company: Kaleido Biosciences, Inc.
\nSymbol: KLDO
\nDescription: They are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley
\nCo-Manager(s): Canaccord Genuity
\nFiled: 1-11-19
\nListed Cash Raise: $100m<\/p>\n

Company: TCR2 Therapeutics Inc.
\nSymbol: TCRR
\nDescription: They are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Leerink, BMO Capital
\nCo-Manager(s): Wedbush Capital, China Renaissance
\nFiled: 12-28-18
\nListed Cash Raise: $100m<\/p>\n

Company: Futu Holdings Limited
\nSymbol: FHL
\nDescription: They are an advanced technology company transforming the investing experience by offering a fully digitized brokerage platform.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, UBS, Credit Suisse
\nFiled: 12-28-18
\nListed Cash Raise: $300m<\/p>\n

Company: Harpoon Therapeutics, Inc.
\nSymbol: HARP
\nDescription: They are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body\u2019s immune system to treat patients suffering from cancer and other diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, SVB Leerink
\nCo-Manager(s): Canaccord Genuity, Wedbush PacGrow
\nFiled: 1-4-19
\nListed Cash Raise: $86.25m<\/p>\n

Company: Super League Gaming, Inc.
\nSymbol: SLGG
\nDescription: They are a leading amateur esports community and content platform offering a personalized experience to the large and underserved global audience of 2.3 billion gamers, as estimated by NewZoo.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Northland Capital, Lake Street
\nCo-Manager(s): National Securities Corporation
\nFiled: 1-4-19
\nListed Cash Raise: $25m<\/p>\n

Company: Poseida Therapeutics, Inc.
\nSymbol: PSTX
\nDescription: They are a clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Credit Suisse, Wells Fargo
\nFiled: 1-4-19
\nListed Cash Raise: $1155m<\/p>\n

Company: Stealth BioTherapeutics Inc.
\nSymbol: MITO
\nDescription: They are a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Evercore, BMO Capital
\nCo-Manager(s): Nomura
\nFiled: 12-28-18
\nListed Cash Raise: $86.25m<\/p>\n

Company: Gossamer Bio, Inc.
\nSymbol: GOSS
\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Leerink, Barclays, Evercore ISI
\nFiled: 12-21-18
\nListed Cash Raise: $264.5m<\/p>\n","protected":false},"excerpt":{"rendered":"

NEW FILINGS Company: Alector, Inc. Symbol: ALEC Description: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Shares: TBD Price Range: TBD Trade Date: TBD Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays Filed: 1-7-19 Listed Cash Raise: $100m Company: Anchiano Therapeutics Ltd. Symbol: ANCN Description:[…]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-6662","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=6662"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6662\/revisions"}],"predecessor-version":[{"id":6663,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6662\/revisions\/6663"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=6662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=6662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=6662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}